1066803

Bioreliance Ltd. — FEI 3005619549

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 10, 2017
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Stirling, Scotland (United Kingdom)

Additional Details

Mutual Recognition Agreement (MRA)